TP53 and cancer: Azurin’s anticancer action has been credited to various components, including the accompanying: (I) cancer development restraint by avoiding angiogenesis by lowering the action of VEGFR-2 tyrosine kinase; (ii) obstruction with protein articulation of P-cadherin and inhibiting tumor growth; (iii) impedance with the Eph-Ephrin Pathway; (iv) p53 protein stabilization and (v) redox homeostasis regulation.